Impact of Baseline Characteristics on the Efficacy and Safety of Eptinezumab in Patients With Migraine: Subgroup Analyses of PROMISE-1 and PROMISE-2
- DOI
- 10.1016/j.clinthera.2022.01.006
- Published
- 2022-03
- Container
- Clinical Therapeutics
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.clinthera.2022.01.006,
title = {Impact of Baseline Characteristics on the Efficacy and Safety of Eptinezumab in Patients With Migraine: Subgroup Analyses of PROMISE-1 and PROMISE-2},
author = {Vincent Martin and A. Jim Nagy and Marina Janelidze and Gvantsa Giorgadze and Joe Hirman and Roger Cady and Lahar Mehta and Dawn C. Buse},
year = {2022},
journal = {Clinical Therapeutics},
doi = {10.1016/j.clinthera.2022.01.006},
url = {https://doi.org/10.1016/j.clinthera.2022.01.006}
}RIS
TY - JOUR TI - Impact of Baseline Characteristics on the Efficacy and Safety of Eptinezumab in Patients With Migraine: Subgroup Analyses of PROMISE-1 and PROMISE-2 AU - Vincent Martin AU - A. Jim Nagy AU - Marina Janelidze AU - Gvantsa Giorgadze AU - Joe Hirman AU - Roger Cady AU - Lahar Mehta AU - Dawn C. Buse PY - 2022 JO - Clinical Therapeutics DO - 10.1016/j.clinthera.2022.01.006 UR - https://doi.org/10.1016/j.clinthera.2022.01.006 ER -
APA
Martin, V., Nagy, A. J., Janelidze, M., Giorgadze, G., Hirman, J., Cady, R., Mehta, L., & Buse, D. C. (2022). Impact of Baseline Characteristics on the Efficacy and Safety of Eptinezumab in Patients With Migraine: Subgroup Analyses of PROMISE-1 and PROMISE-2. Clinical Therapeutics. https://doi.org/10.1016/j.clinthera.2022.01.006
Source records
- crossref · retrieved 2026-09-27T14:28:39.783Z